Rau M, Thiele K, Korbinian Hartmann NU, Mollmann J, et al. Effects of empagliflozin on lipoprotein subfractions in patients with type 2 diabetes: data from a randomized, placebo-controlled study. Atherosclerosis 2021;330:8-13.
PMID: 34218214